368 related articles for article (PubMed ID: 27245896)
1. Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors.
Soethoudt M; van Gils N; van der Stelt M; Heitman LH
Methods Mol Biol; 2016; 1412():103-11. PubMed ID: 27245896
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
3. Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.
Bouma J; Soethoudt M; van Gils N; Xia L; van der Stelt M; Heitman LH
Methods Mol Biol; 2023; 2576():189-199. PubMed ID: 36152187
[TBL] [Abstract][Full Text] [Related]
4. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.
van der Lee MM; Blomenröhr M; van der Doelen AA; Wat JW; Smits N; Hanson BJ; van Koppen CJ; Zaman GJ
J Biomol Screen; 2009 Aug; 14(7):811-23. PubMed ID: 19520790
[TBL] [Abstract][Full Text] [Related]
6. Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay.
McGuinness D; Malikzay A; Visconti R; Lin K; Bayne M; Monsma F; Lunn CA
J Biomol Screen; 2009 Jan; 14(1):49-58. PubMed ID: 19171920
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
8. Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists.
Dhopeshwarkar A; Murataeva N; Makriyannis A; Straiker A; Mackie K
J Pharmacol Exp Ther; 2017 Feb; 360(2):300-311. PubMed ID: 27927913
[TBL] [Abstract][Full Text] [Related]
9. Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB
Ryalls B; Patel M; Sparkes E; Banister SD; Finlay DB; Glass M
Biochem Pharmacol; 2024 Apr; 222():116052. PubMed ID: 38354957
[TBL] [Abstract][Full Text] [Related]
10. Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.
Taylor L; Christou I; Kapellos TS; Buchan A; Brodermann MH; Gianella-Borradori M; Russell A; Iqbal AJ; Greaves DR
Sci Rep; 2015 Jun; 5():10682. PubMed ID: 26033291
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans.
Li C; Bowe JE; Huang GC; Amiel SA; Jones PM; Persaud SJ
Diabetes Obes Metab; 2011 Oct; 13(10):903-10. PubMed ID: 21564460
[TBL] [Abstract][Full Text] [Related]
12. Characterization of structurally novel G protein biased CB
Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
[TBL] [Abstract][Full Text] [Related]
13. Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway.
Dhopeshwarkar A; Mackie K
J Pharmacol Exp Ther; 2016 Aug; 358(2):342-51. PubMed ID: 27194477
[TBL] [Abstract][Full Text] [Related]
14. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
Laroche G; Giguère PM
Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
[TBL] [Abstract][Full Text] [Related]
15. The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor.
Leo LM; Al-Zoubi R; Hurst DP; Stephan AP; Zhao P; Tilley DG; Miess E; Schulz S; Abood ME; Reggio PH
Cannabis Cannabinoid Res; 2023 Oct; 8(5):731-748. PubMed ID: 35792570
[No Abstract] [Full Text] [Related]
16. The influence of beta-arrestin2 on cannabinoid CB1 receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brain.
Breivogel CS; Puri V; Lambert JM; Hill DK; Huffman JW; Razdan RK
J Recept Signal Transduct Res; 2013 Dec; 33(6):367-79. PubMed ID: 24094141
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence.
Ibsen MS; Finlay DB; Patel M; Javitch JA; Glass M; Grimsey NL
Front Pharmacol; 2019; 10():350. PubMed ID: 31024316
[TBL] [Abstract][Full Text] [Related]
19. A novel luminescence-based β-arrestin recruitment assay for unmodified receptors.
Hauge Pedersen M; Pham J; Mancebo H; Inoue A; Asher WB; Javitch JA
J Biol Chem; 2021; 296():100503. PubMed ID: 33684444
[TBL] [Abstract][Full Text] [Related]
20. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
